{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:35:35Z","timestamp":1761557735636,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.sapharm.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T19:05:46Z","timestamp":1686855946000},"page":"1360-1364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists\u2019 scope of practice"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6642-2519","authenticated-orcid":false,"given":"Teresa A.","family":"Beam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald G.","family":"Klepser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Klepser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Bright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicklas","family":"Klepser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Schuring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Langerveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.sapharm.2023.06.003_bib1","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMp2107331","article-title":"Integrating research into community practice \u2014 toward increased diversity in clinical trials","volume":"385","author":"Woodcock","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.sapharm.2023.06.003_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.9132","article-title":"Evaluation of frequency of encounters with primary care physicians vs visits to community pharmacies among medicare beneficiaries","volume":"3","author":"Berenbrok","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.sapharm.2023.06.003_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.omtm.2020.06.017","article-title":"The two faces of ACE2: the role of ACE2 receptor and its polymorphisms in hypertension and COVID-19","volume":"18","author":"Bosso","year":"2020","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"issue":"11","key":"10.1016\/j.sapharm.2023.06.003_bib7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.tig.2020.08.003","article-title":"Host polymorphisms may impact SARS-CoV-2 infectivity","volume":"36","author":"Brest","year":"2020","journal-title":"Trends Genet"},{"issue":"11","key":"10.1016\/j.sapharm.2023.06.003_bib8","doi-asserted-by":"crossref","first-page":"10087","DOI":"10.18632\/aging.103415","article-title":"ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy","volume":"12","author":"Asselta","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.sapharm.2023.06.003_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104507","article-title":"A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3\/7\/8 across populations","volume":"85","author":"Lee","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"9","key":"10.1016\/j.sapharm.2023.06.003_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1099\/jgv.0.001452","article-title":"Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection","volume":"101","author":"Wang","year":"2020","journal-title":"J Gen Virol"},{"key":"10.1016\/j.sapharm.2023.06.003_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3389\/fgene.2020.00861","article-title":"Infectivity and progression of COVID-19 based on selected host candidate gene variants","volume":"11","author":"Iyer","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.sapharm.2023.06.003_bib12","article-title":"Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility","author":"Stawiski","year":"2020","journal-title":"Genetics"},{"key":"10.1016\/j.sapharm.2023.06.003_bib13","article-title":"ACE2 Polymorphisms and individual Susceptibility to SARS-CoV-2 infection: Insights from an in silico study","author":"Calcagnile","year":"2020","journal-title":"Microbiology"},{"issue":"1","key":"10.1016\/j.sapharm.2023.06.003_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov"},{"issue":"7","key":"10.1016\/j.sapharm.2023.06.003_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13168","article-title":"Individual variation of the SARS\u2010CoV\u20102 receptor ACE2 gene expression and regulation","volume":"19","author":"Chen","year":"2020","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.sapharm.2023.06.003_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/22221751.2021.1902755","article-title":"Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers","volume":"10","author":"Mart\u00ednez-Sanz","year":"2021","journal-title":"Emerg Microb Infect"},{"issue":"1","key":"10.1016\/j.sapharm.2023.06.003_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/infdis\/jiaa224","article-title":"Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019","volume":"222","author":"Zhang","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.sapharm.2023.06.003_bib18","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10402","article-title":"The frequency of combined IFITM3 haplotype involving the reference alleles of both rs12252 and rs34481144 is in line with COVID-19 standardized mortality ratio of ethnic groups in England","volume":"8","author":"Nikoloudis","year":"2020","journal-title":"PeerJ"},{"issue":"8","key":"10.1016\/j.sapharm.2023.06.003_bib19","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/491479","article-title":"Association between mannose-binding lectin gene polymorphisms and susceptibility to severe Acute respiratory Syndrome coronavirus infection","volume":"192","author":"Zhang","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.sapharm.2023.06.003_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12879-015-0879-y","article-title":"Impact of MBL and MASP-2 gene polymorphism and its interaction on susceptibility to tuberculosis","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.sapharm.2023.06.003_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2019.01005","article-title":"Evaluation of mannose binding lectin gene variants in pediatric influenza virus-related critical illness","volume":"10","author":"Levy","year":"2019","journal-title":"Front Immunol"},{"issue":"7848","key":"10.1016\/j.sapharm.2023.06.003_bib22","first-page":"92","article-title":"The GenOMICC Investigators, The ISARIC4C Investigators, The COVID-19 Human Genetics Initiative, et al. Genetic mechanisms of critical illness in COVID-19","volume":"591","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.sapharm.2023.06.003_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MPG.0b013e318246be78","article-title":"STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric crohn disease","volume":"55","author":"Willson","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.sapharm.2023.06.003_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2023.06.003_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.virol.2017.08.009","article-title":"Association of toll-like receptor polymorphisms with susceptibility to chikungunya virus infection","volume":"511","author":"Dutta","year":"2017","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.sapharm.2023.06.003_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026235","article-title":"TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2023.06.003_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2020.08.008","article-title":"An assessment of toll-like receptor 7 and 8 gene polymorphisms with susceptibility to HIV-1 infection, AIDS development and response to antiretroviral therapy","volume":"227","author":"Zaidane","year":"2020","journal-title":"Immunol Lett"},{"issue":"9","key":"10.1016\/j.sapharm.2023.06.003_bib28","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/genes11091010","article-title":"COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells","volume":"11","author":"Latini","year":"2020","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.sapharm.2023.06.003_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/genes12010019","article-title":"Structural variability, expression profile, and pharmacogenetic properties of TMPRSS2 gene as a potential target for COVID-19 therapy","volume":"12","author":"Zarubin","year":"2020","journal-title":"Genes"},{"issue":"302","key":"10.1016\/j.sapharm.2023.06.003_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/14786440009463897","article-title":"On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling","volume":"50","author":"Pearson","year":"1900","journal-title":"London, Edinburgh Dublin Phil Mag J Sci"},{"year":"1992","series-title":"ANOVA: Repeated Measures","author":"Girden","key":"10.1016\/j.sapharm.2023.06.003_bib31"},{"issue":"12","key":"10.1016\/j.sapharm.2023.06.003_bib32","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1007\/s11033-013-2809-7","article-title":"Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection","volume":"40","author":"Grzegorzewska","year":"2013","journal-title":"Mol Biol Rep"},{"issue":"7835","key":"10.1016\/j.sapharm.2023.06.003_bib33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41586-020-2818-3","article-title":"The major genetic risk factor for severe COVID-19 is inherited from Neanderthals","volume":"587","author":"Zeberg","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.sapharm.2023.06.003_bib34","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/SLA.0000000000004078","article-title":"Global overview of response rates in patient and health care professional surveys in surgery: a systematic Review","volume":"275","author":"Meyer","year":"2022","journal-title":"Ann Surg"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112300298X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112300298X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:31:08Z","timestamp":1761557468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155174112300298X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S155174112300298X"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.06.003","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists\u2019 scope of practice","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}